Search results
Eli Lilly details NASH effects of weight loss drug (NYSE:LLY)
Seeking Alpha· 3 hours agoEli Lilly (LLY) posts detailed mid-stage results highlighting the benefits of its weight loss drug...
Eli Lilly CFO Anat Ashkenazi steps down By Investing.com
Investing.com· 55 minutes agoEli Lilly and Company (NYSE: NYSE:LLY) announced today that Anat Ashkenazi has resigned from her...
Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH
Investor's Business Daily· 41 minutes agoShares of other drugmakers working on treatments for MASH also tumbled. Akero Therapeutics lost...
Alphabet Picks Eli Lilly Executive Anat Ashkenazi As New CFO
Investor's Business Daily· 31 minutes agoGoogle-parent Alphabet announced that its new chief financial officer will be Anat Ashkenazi,...
Google Parent Alphabet Appoints Eli Lilly's Finance Chief Ashkenazi As CFO
Benzinga via Yahoo Finance· 1 hour agoOn Wednesday, Eli Lilly And Co (NYSE:LLY) announced that Anat Ashkenazi has resigned as chief...
Google taps Eli Lilly finance chief as its new CFO
Quartz· 3 hours agoAfter almost a year of searching, Google parent Alphabet has finally found a replacement for its chief financial officer position. The tech giant has...
Alphabet names Eli Lilly CFO Anat Ashkenazi its new chief of finance
Invezz· 2 hours agoAlphabet Inc (NASDAQ: GOOGL) is in focus today after naming Anat Ashkenazi as its new chief of...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 6 days agoEli Lilly stock rocketed and broke out earlier this month after unveiling promising results for its...
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
The Motley Fool via AOL· 4 days agoNovo Nordisk and Eli Lilly are the early leaders in the GLP-1 weight loss market, but that may not be the case years down the road. Plus...weight loss pill ...
Alphabet names Lilly executive Anat Ashkenazi as CFO
Reuters via Yahoo News· 4 hours ago(Reuters) -Alphabet named Anat Ashkenazi as its chief financial officer on Wednesday, turning to a top executive from drugmaker Eli Lilly to help steer...